Skip to main content
Log in

Prostatic Artery Embolization Allows to Maintain Full Sexual Activity in Patients Suffering from Bothersome Lower Urinary Tracts Symptoms related to Benign Prostatic Hyperplasia

  • CLINICAL INVESTIGATION
  • Embolisation (arterial)
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Introduction

The effect of prostate artery embolization (PAE) on male sexual function is currently the subject of debate in the literature. The main purpose of this study was to define changes in all domains of sexual activity after PAE, using the international index of erectile function score (IIEF-15).

Methods

A single-center retrospective study was conducted on 129 patients (mean age of 65.5 ± 7 years), who underwent PAE from February 2014 to January 2017 for symptomatic benign prostatic hyperplasia (BPH). Fifty consecutive patients fulfilling the inclusion criteria were evaluated before and after PAE follow-up using the IIEF-15, IPSS, prostate volume (PV) and cardiovascular risk factor and BPH drugs. The IIEF-15 domains analyzed were: erectile function (EF) ejaculation and orgasm (Ej/O), sexual desire (SD), intercourse satisfaction (IS) and overall satisfaction (OS). A paired sample t test or Wilcoxon signed-rank test was used to compare IIEF-15 between baseline and follow-up.

Results

The study showed nonsignificant change in IIEF-15 total score (58.0 ± 13.8 SD; p = 0.71) and the five domains (EF 24.5 ± 7.0 SD, p = 0.82; EJ/O 8.2 ± 2.3 SD, p = 0.50; SD 7.2 ± 2.7 SD, p = 0.57; IS 10.3 ± 3.0 SD, p = 0.77; OS 8.2 ± 2.7 SD; p = 0.11) after PAE. We also found a significant improvement in IPSS score after PAE.

Conclusion

Based on the IIEF-15 questionnaire, PAE was showed to allow good urinary symptoms results and no deterioration in sexual function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lepor H. Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol. 2004;6(Suppl 9):S3–S10.

    PubMed  PubMed Central  Google Scholar 

  2. Bruskewitz RC. Quality of life and sexual function in patients with benign prostatic hyperplasia. Rev Urol. 2003;5:72–80.

    PubMed  PubMed Central  Google Scholar 

  3. Frankel SJ, Donovan JL, Peters TI, et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol. 1998;51:677–85.

    Article  CAS  Google Scholar 

  4. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003 D;44(6):637–49.

    Article  Google Scholar 

  5. Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82.

    Article  Google Scholar 

  6. Pisco JM, Bilhim T, Pinheiro LC. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27(8):1115–22.

    Article  Google Scholar 

  7. Rampoldi A, Barbosa F, Secco S, et al. Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates. Cardiovasc Interv Radiol. 2017;40:530–6.

    Article  Google Scholar 

  8. de Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates %3e 90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26:87–93.

    Article  Google Scholar 

  9. Teoh JY, Chiu PK, Yee CH, et al. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review. Int Urol Nephrol. 2017;49:197–203.

    Article  Google Scholar 

  10. Shim SR, Kanhai KJ, Ko YM, Kim JH. Efficacy and safety of prostatic arterial embolization: systematic review with meta analysis and meta-regression. J Urol. 2017;197(2):465–79.

    Article  Google Scholar 

  11. Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361:k2338.

    Article  Google Scholar 

  12. Müllhaupt G, Hechelhammer, L, Diener PA et al. Ejaculatory disorders after prostatic artery embolization: a reassessment of two prospective clinical trials. World J Urol. 2019.

  13. Uflacker A, Patrie J, Haskal ZJ. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia-review of 12-month outcomes data. J Vasc Interv Radiol. 2016;27(11):1686–1697.e8.

    Article  Google Scholar 

  14. Carnevale FC, Moreira AM, Antunes AA. The ‘‘Perfected technique’’: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2014;37:1602–5.

    Article  Google Scholar 

  15. Rosen R, Riley A, Wagner G, et al. The international index of 1 erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    Article  CAS  Google Scholar 

  16. Dargis L, Trudel G, Cadieux J, et al. Validation of the international index of erectile function (IIEF) and presentation of norms in older men. Sexologies. 2013. https://doi.org/10.1016/j.sexol.2012.01.001.

    Article  Google Scholar 

  17. Bagla S, Smirniotopoulos JB, Orlando JC, van Breda A, Vadlamudi V. Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. Vasc Interv Radiol. 2015;26(12):1832–8.

    Article  Google Scholar 

  18. Kurbatov D, Russo GI, Lepetukhin A, et al. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study. Urology. 2014;84:400–4.

    Article  Google Scholar 

  19. Pyo JS, Cho WJ. Systematic review and meta-analysis of prostatic artery embolisation for lower urinary tract symptoms related to benign prostatic hyperplasia. Clin Radiol. 2017;72(1):16–22.

    Article  Google Scholar 

  20. Hellstrom WJ, Giuliano F, Rosen RC. Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment. Urology. 2009;74(1):15–211.

    Article  Google Scholar 

  21. Vallancien G, Emberton M, Harving N, van Moorselaar RJ. Alf-one study group sexual dysfunction in 1274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169(6):2257–61.

    Article  Google Scholar 

  22. Cho MC, Kim JK, Song SH, et al. Patient-reported ejaculatory function and satisfaction in men with lower urinary tract symptoms/benign prostatic hyperplasia. Asian J Androl. 2018;20(1):69–74.

    Article  CAS  Google Scholar 

  23. DeLay KJ, Nutt M, McVary KT. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms. Transl Androl Urol. 2016;5(4):450–9.

    Article  Google Scholar 

  24. Oelke M et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European 1 urology. Available on: https://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS_LR.pdf.

  25. Pavone C, Abbadessa D, Scaduto G, et al. Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients. Arch Ital Urol Androl. 2015;87(1):8–13. https://doi.org/10.4081/aiua.2015.1.8.

    Article  CAS  PubMed  Google Scholar 

  26. Oka AAG, Duarsa GWK, Novianti PA, et al. The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia. Res Rep Urol. 2019;11:91–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–97.

    Article  Google Scholar 

Download references

Acknowledgements

I acknowledge the cooperation of all the staff of the Vascular and Oncological Interventional Radiology Department of the Hôpital Européen Georges Pompidou Paris who participated. We also appreciate the compliance of the patients.

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ludovica Marzano or Marc Sapoval.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

This study is a data collection. The patients were informed that their data could be used for research purposes and could refuse it. The data collection was approved by the CPP Ile de France 2 under the reference CERHUPO 2015-06-05.

Informed Consent

For this type of study, consent for publication is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marzano, L., Thiounn, N., Pereira, H. et al. Prostatic Artery Embolization Allows to Maintain Full Sexual Activity in Patients Suffering from Bothersome Lower Urinary Tracts Symptoms related to Benign Prostatic Hyperplasia. Cardiovasc Intervent Radiol 43, 1202–1207 (2020). https://doi.org/10.1007/s00270-020-02520-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-020-02520-7

Keywords

Navigation